INVO Bioscience, Inc. - INVO
About Gravity Analytica
Recent News
- 11.05.2026 - INVO Fertility Partners with PatientFi to Help Make Fertility Treatment More Affordable
- 10.27.2026 - INVO Fertility Announces a 1:4 Reverse Stock Split Effective Pre-Market Opening on October 30, 2026
- 06.22.2026 - INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
- 06.02.2026 - INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
- 06.02.2026 - INVO Fertility Announces Fiscal Year 2025 Financial Results
- 04.29.2026 - INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
- 03.25.2026 - INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
- 03.05.2026 - INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
- 03.03.2026 - INVO Fertility’s Wisconsin Clinic Joins Progyny Network
- 02.19.2026 - INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
Recent Filings
- 11.04.2026 - 8-K Current report
- 11.04.2026 - EX-99.1 EX-99.1
- 10.09.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.28.2026 - S-8 Securities to be offered to employees in employee benefit plans
- 08.28.2026 - 8-K Current report
- 08.28.2026 - EX-99.1 EX-99.1
- 08.17.2026 - 8-K Current report
- 08.17.2026 - EX-99.1 EX-99.1
- 08.14.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 08.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]